Purchases and Sales Made in Q3 2022 in Pyxis Oncology, Inc. (PYXS)
This table provides information about the institutional ownership of Pyxis Oncology, Inc. (PYXS) during Q3 2022. The information is specifically focused on institutions that hold shares of Pyxis Oncology, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Orbimed Advisors LLC
San Diego, CA |
BUY
|
- |
848KNew |
$1.59M - $2.57M
|
848K
$1.69M
|
|
|
Nov 14, 2022
Q3 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
79K+ 71.89% |
$148K - $239K
|
189K
$376K
|
|
|
Nov 14, 2022
Q3 2022
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
68.3K+ 8.04% |
$128K - $207K
|
917K
$1.83M
|
|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
53.4K+ 70.89% |
$100K - $162K
|
129K
$256K
|
|
|
Nov 14, 2022
Q3 2022
|
Bridgeway Capital Management, LLC
Houston, TX |
BUY
|
- |
50K+ 71.13% |
$94K - $152K
|
120K
$239K
|
|
|
Nov 14, 2022
Q3 2022
|
Acuta Capital Partners, LLC
Belmont, CA |
BUY
|
- |
24K+ 3.72% |
$45.1K - $72.7K
|
669K
$1.33M
|
|
|
Nov 14, 2022
Q3 2022
|
Charles Schwab Investment Management Inc
San Francisco, CA |
BUY
|
- |
17.7KNew |
$33.3K - $53.7K
|
17.7K
$35.3K
|
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
12.7K+ 414.25% |
$23.8K - $38.4K
|
15.7K
$31.3K
|
|
|
Nov 14, 2022
Q3 2022
|
Prelude Capital Management, LLC
New York, NY |
BUY
|
- |
11.1KNew |
$20.8K - $33.5K
|
11.1K
$22K
|
|
|
Nov 14, 2022
Q3 2022
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
BUY
|
- |
10.4KNew |
$19.6K - $31.5K
|
10.4K
$20.7K
|
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
9.85K+ 0.65% |
$18.5K - $29.8K
|
1.53M
$3.05M
|
|
|
Nov 14, 2022
Q3 2022
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
8.66K+ 48.79% |
$16.3K - $26.2K
|
26.4K
$52.5K
|
|
|
Nov 14, 2022
Q3 2022
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
4.35K+ 27.67% |
$8.18K - $13.2K
|
20.1K
$40K
|
|
|
Nov 14, 2022
Q3 2022
|
Black Rock Inc.
New York, NY |
BUY
|
- |
1.25K+ 0.61% |
$2.35K - $3.79K
|
207K
$411K
|
|
|
Nov 14, 2022
Q3 2022
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
192New |
$361 - $582
|
192
$382
|
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
76+ 108.57% |
$143 - $230
|
146
$291
|
|
|
Nov 14, 2022
Q3 2022
|
Cormorant Asset Management, LP
Boston, MA |
BUY
|
- |
1+ 0.0% |
$1.88 - $3.03
|
669K
$1.33M
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 10, 2022
Q3 2022
|
Citigroup Inc
|
SELL
|
- |
-103- 0.03% |
$194 - $312
|
312K
$621K
|
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
SELL
|
- |
-212- 57.77% |
$399 - $642
|
155
$308
|
|
|
Nov 14, 2022
Q3 2022
|
Legal & General Group PLC
London, X0 |
SELL
|
- |
-833Closed |
$1.57K - $2.52K
|
0
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-4.62K- 10.92% |
$8.68K - $14K
|
37.7K
$75K
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-14.9K- 10.87% |
$28K - $45.1K
|
122K
$243K
|
|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-53K- 37.09% |
$99.6K - $161K
|
89.8K
$179K
|
|
|
Nov 14, 2022
Q3 2022
|
Ra Capital Management, L.P.
Boston, MA |
SELL
|
- |
-189K- 19.8% |
$355K - $572K
|
765K
$1.52M
|
|
|
Nov 10, 2022
Q3 2022
|
Credit Suisse Ag
Zurich, V8 |
SELL
|
- |
-813K- 84.25% |
$1.53M - $2.46M
|
152K
$303K
|